| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8945333 | European Journal of Surgical Oncology (EJSO) | 2018 | 7 Pages |
Abstract
This two-center study shows that in men with BC in whom the prostate and PU were proven free of malignancy, PSC would represent a valid treatment option with excellent functional outcome. Oncologic outcomes were comparable to what is known from radical cystoprostatectomy series.
Keywords
CSSCSMTURTRUSCICPSCBCGNeobladderPLNDRFSCISPSABacillus Calmette-GuérinProstate specific antigenimmCancer specific survivalRecurrence-free survivaloverall survivalPelvic lymph node dissectionPositron emission tomographyTransurethral resectionBladder cancerTransrectal ultrasoundCystectomyRadical cystectomyconfidence intervalCancer specific mortalityPETclean intermittent catheterizationCarcinoma in situBladder carcinomaProstatic urethra
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Charlotte S. Voskuilen, Elisabeth E. Fransen van de Putte, Jose I. Pérez-Reggeti, Erik van Werkhoven, Laura S. Mertens, Bas W.G. van Rhijn, Mohamed Saad, Axel Bex, Xavier Cathelineau, Henk G. van der Poel, Simon Horenblas, Rafael Sanchez-Salas,